Pay in 4 interest-free payments of $5.54 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
It acts as a melanocortin receptor agonist, primarily targeting MC3R and MC4R in the central nervous system
Common adverse effects include gastrointestinal symptoms such as nausea, vomiting, diarrhea, and constipation, which typically diminish with gradual dose titration
Dysesthesia This covers abnormal sensations that do not fit neatly into pain or sensitivity categories
As with compounded semaglutide, the general active ingredient category is similar, but the regulatory status is different
Studies have shown GLP-1s reduce the desire to drink in people taking them for other conditions
Retatrutide is an investigational triple hormone receptor agonist with no regulatory approval
US$ 29.61
US$ 22.59
US$ 23.49
US$ 21.51
US$ 28.73
US$ 25.88
US$ 29.64
US$ 28.35
